Wienerberger Insiders Back the Stock as Guidance Cuts and Index Exit Test Investor Nerve

The brickmaker’s leadership suite is putting its money where its mouth is. Gerhard Hanke, who stepped into the chief executive role on an interim basis earlier this month, purchased shares on 13 August, followed two days later by supervisory board chairman Peter Steiner. Those insider transactions landed at a delicate moment for the Vienna-listed group, which is juggling a profit warning, a CEO departure and an imminent index expulsion.

A Health-Driven Handover

Heimo Scheuch’s resignation as chief executive was announced via ad-hoc disclosure on 10 August, with the company citing health reasons. The news landed just ahead of the half-year results, which were published on 12 August. Hanke, previously a board member, took over the top job on a temporary footing. The abruptness of the transition caught the market off guard, though the subsequent insider purchases have given investors something to chew on — such buying in the immediate aftermath of a leadership change is often read as a confidence signal, even if the company itself offered no commentary on the trades.

A Sharp Markdown in Earnings Expectations

The operational picture that greeted the new CEO was far from pretty. Wienerberger has slashed its full-year guidance, now targeting operating EBITDA of roughly €700 million against an earlier projection of about €810 million. The culprit is a weak second quarter: while revenue climbed 13 percent to €1,409 million, operating EBITDA fell 9 percent to €230 million.

The first half tells a similar story. Revenue rose 4 percent to €2,434 million, but operating EBITDA dropped 15 percent to €326 million. The pain is concentrated across the Atlantic — the Americas business collapsed by 35 percent year-on-year in the second quarter.

The weaker earnings outlook has forced a recalibration of the balance sheet targets. Net debt to EBITDA is now expected to land at 2.8x by year-end, up from the previously guided 2.2x — a signal that the group is running a tighter financial ship even as it continues to bolt on acquisitions.

Acquisitions Continue, Strategy Shifts

Despite the operational strain, the M&A machine has kept turning. Wienerberger completed the takeovers of Italcer, a ceramic tile specialist, and NEWS Group, which operates in water management, during the second quarter. The deals underscore a strategic pivot toward infrastructure and renovation — segments that now account for more than 60 percent of group revenue.

Should investors sell immediately? Or is it worth buying Wienerberger?

That repositioning has done little to arrest the share price slide. The stock closed Friday at €19.25, up 2.2 percent on the day, but still well adrift of its 200-day moving average of €25.19. The monthly decline stands at 14 percent, and the equity has shed 37 percent since the start of the year. With the 52-week low of €18.47 — touched as recently as 3 September — sitting just over 4 percent below the current price, the shares are hovering dangerously close to their floor.

Analysts and Index Providers Turn the Screw

The valuation picture has become historically cheap, a fact that prompted Raiffeisen Research to cut its price target on 31 August from €28.0 to €21.0 while maintaining a buy recommendation. The move was justified by the sharp year-to-date decline, which has left the company’s valuation metrics at unusually low levels. Automated valuation models have also been revised downward, anchoring the fair value assessment lower than before.

Technical headwinds are compounding the fundamental weakness. STOXX has announced Wienerberger’s removal from the STOXX Europe 600, effective 21 September. Index-tracking funds will be forced to sell their positions to mirror the new composition, adding further selling pressure to an already battered stock.

Regulatory Clouds in the Netherlands

In the background, Dutch authorities are reviewing discharge-related permit applications involving subsidiary Wienerberger B.V. at its Opheusden and Zennewijnen sites. The proceedings concern the local Dutch entity and cannot be directly extrapolated to the parent company, but they inject another layer of uncertainty into an already complicated picture.

What Comes Next

The market’s attention now turns to the next quarterly report, scheduled for 12 November. That will be the first real test of whether the US downturn is stabilising or whether the reduced full-year forecast comes under renewed pressure. For the new interim CEO, the immediate challenge is clear: convincing investors that the worst is behind a company facing a health-related leadership vacuum, a profit warning, an index exit and regulatory scrutiny all at once. The insider purchases suggest the board believes in the story — the market, for now, remains unconvinced.